RemeGen has submitted a Biologics License Application (BLA) to the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) in China for IgAN, which if approved would ...
15h
Travere Therapeutics to Present Abstracts at American Society of Nephrology (ASN) Kidney Week 2025
Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced that the Company will present 11 abstracts, including a late-breaking poster, at the upcoming American Society of Nephrology (ASN) Kidney Week ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback